Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Irinotecan in small-cell lung cancer: current data.

K Kelly1

  • 1University of Colorado Cancer Center, Denver, CO, USA. karen.kelly@UCHSC.edu

Clinical Lung Cancer
|January 17, 2004
PubMed
Summary

Irinotecan shows significant activity in small-cell lung cancer (SCLC) treatment. A combination with cisplatin offers a survival advantage, marking a major advance for extensive-stage SCLC.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Healthcare should be accessible for all: development of the ObServation Tool and Resource for Inclusive Communication in Healthcare (OSTRICH).

Disability and rehabilitation·2026
Same author

Global advances and future directions in lung cancer care: expert consensus and strategic priorities.

ESMO open·2026
Same author

Lung cancer research and treatment: global perspectives and strategic calls to action.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

An interprofessional clinic for adults with Turner syndrome: the patient perspective.

Climacteric : the journal of the International Menopause Society·2022
Same author

Corrigendum to "The incidence, aetiology, and coagulation management of massive postpartum haemorrhage: a two-year national prospective cohort study" [Int J Obstet Anesth. 2021;47:102983].

International journal of obstetric anesthesia·2022
Same author

The incidence, aetiology, and coagulation management of massive postpartum haemorrhage: a two-year national prospective cohort study.

International journal of obstetric anesthesia·2021

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Small-cell lung cancer (SCLC) treatment has seen limited progress.
  • Irinotecan is a novel topoisomerase I inhibitor with demonstrated anti-cancer activity.

Purpose of the Study:

  • To evaluate the efficacy of irinotecan in SCLC treatment.
  • To highlight recent advancements in SCLC therapy using irinotecan.

Main Methods:

  • Review of clinical trial data on irinotecan in SCLC.
  • Analysis of combination therapies involving irinotecan and other agents like cisplatin, carboplatin, etoposide, and paclitaxel.

Main Results:

  • Irinotecan demonstrates significant activity in both untreated and previously treated SCLC patients.
  • A Japanese randomized trial showed a survival advantage for irinotecan plus cisplatin over cisplatin/etoposide in chemotherapy-naive extensive-stage SCLC.
  • Preliminary results of ongoing trials incorporating irinotecan are encouraging.

Conclusions:

  • Irinotecan represents a significant advancement in extensive-stage SCLC treatment.
  • Further research and clinical trials are ongoing to explore irinotecan's role in limited-stage SCLC and in combination with various agents.

Related Experiment Videos